Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

IEC & IPC Joint Symposium: Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script

2026 ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGY (AAD) | DENVER, COLORADO, UNITED STATES

March 26, 2026
 | 14:00-18:00 MDT
Location: Denver Convention Center, Room: Blue Bird Ballroom 3EF, Floor 3

Add this event to your calendar

Apple Google Outlook Outlook.com Office 365 Yahoo

This educational session will explore the clinical challenges of distinguishing between psoriasis and atopic dermatitis in non-classic
presentations, including psoriasiform spongiotic dermatitis and paradoxical drug reactions induced by biologic therapies like anti
TNF or IL-17 inhibitors. Through case studies and evidence-based discussions, participants will learn how to recognize subtle
diagnostic cues and apply the latest treatment strategies, incorporating histopathology and biomarkers into their treatment
decisions. Attendees will gain practical tools to improve diagnostic confidence, optimize patient outcomes, and navigate the
therapeutic complexities of inflammatory skin disease, including mechanistic insights for managing treatment-related rashes.

LEARNING OBJECTIVES

At the conclusion of this symposium, participants will be able to:

  1. Analyze the diagnostic challenges of distinguishing psoriasis from atopic dermatitis in non-classic clinical
    presentations, including recognition of psoriasiform spongiotic dermatitis, by identifying at least three
    distinguishing clinical features.
  2. Evaluate and apply advanced diagnostic strategies, such as histopathology and biomarker testing, to
    differentiate psoriasis, atopic dermatitis, and paradoxical drug reactions, demonstrating the ability to select at
    least two appropriate tools for challenging adult and pediatric cases.
  3. Design and implement evidence-based management plans for paradoxical psoriasiform and eczematous
    eruptions associated with biologic therapies, including TNF-α or IL-17 inhibitors, integrating mechanistic
    insights to optimize skin-related outcomes for patients with psoriasis, atopic dermatitis, or inflammatory bowel
    disease. 

Agenda

Welcome from the IEC & IPC
Alan Irvine, MD, DSc, Ireland
Bruce Strober, MD, PhD, United States

Diagnostic Challenges Between Atopic Dermatitis and Psoriasis
Andrew Pink, PhD, United Kingdom

Eczematous Reactions in Patients Receiving Treatments for Psoriasis

Clinical Presentation
Jason Hawkes, MD, MS, FAAD, United States

Clinical Approach
Kenneth Gordon, MD, United States

Q & A
Moderator: Bruce Strober, MD, PhD, United States

Psoriasiform Reactions in Patients Receiving Treatments for Atopic
Dermatitis & Prurigo Nodularis

Clinical Presentation
Shawn G. Kwatra, MD, United States

Clinical Approach
Yael Anne Leshem, MD, MCR, Israel

What is Psoriasiform Spongiotic Dermatitis? Navigating
Uncertainty Using Advanced Diagnostics

Kilian Eyerich, MD, PhD, Sweden

Q & A
Moderator: Amy Paller, MS, MD, United States

Anti-TNF-a Induced Skin Eruptions in Patients with Inflammatory Bowel Disease

Presentation and Clinical Approach in Adults
Lev Pavlovsky, MD, PhD, Israel

Presentation and Clinical Approach in Children
Amy Paller, MS, MD, United States

Mechanistic Aspects of Paradoxical Reactions and Iatrogenic Switches
Johann Gudjonsson, MD, PhD, United States

Final Q & A
Moderator: Yael Anne Leshem, MD, MCR, Israel

Closing Remarks
Alan Irvine, MD, DSc, Ireland
Bruce Strober, MD, PhD, United States

Program Chairs

Alan Irvine, MD, DSc

Trinity College Dublin, Children’s Health Ireland

Dublin, Ireland

Bio

Yael Anne Leshem, MD, MCR

Rabin Medical Center, Petah Tikva and Tel Aviv University

Tel Aviv, Israel

Bio

Amy Paller, MS, MD

Northwestern University Feinberg Medical School

Chicago, Illinois, United States

IPC Board Member

Bio

Bruce Strober, MD, PhD

Yale University and Central Connecticut Dermatology

Cromwell, Connecticut, United States

IPC President

Bio

Program Faculty

Kilian Eyerich, MD, PhD

University of Freiburg

Freiburg, Germany

IPC Councilor

Bio

Kenneth Gordon, MD

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

IPC Councilor

Bio

Johann Gudjonsson, MD, PhD

University of Michigan, Department of Dermatology

Ann Arbor, Michigan, United States

IPC Board Member

Bio

Jason Hawkes, MD, MS, FAAD

Oregon Medical Research Center (OMRC)

Portland, Oregon, United States

IPC Councilor

Bio

Shawn Kwatra, MD

Johns Hopkins University School of Medicine

Baltimore, Maryland, United States

Bio

Lev Pavlovsky, MD, PhD

Tel Aviv University

Petah-Tikva, Israel

IPC Councilor

Bio

Andrew Pink, PhD

St. John’s Institute of Dermatology, Guy & St. Thomas’ NHS Foundation Trust

London, United Kingdom

IPC Councilor

Bio

This symposium is supported in part by:

Amgen’s Manufacturing is Worldwide Pioneer in Biotechnology

These sponsorships are provided exclusively to the IPC.

What's New

Remembering Dr. Craig Leonardi

The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.

Read More »

Look Beyond My Skin: World Psoriasis Day 2026

World Psoriasis Day, observed each year on October 29, was launched by the International Federation of Psoriasis Associations (IFPA) in 2004 to give a voice to the more than 125 million people worldwide living with psoriasis and psoriatic arthritis. To mark this year’s observance, IPC joined the Latin American Society of Psoriasis and Dermoimmunology (SOLAPSO) and the Skin Inflammation and Psoriasis International Network (SPIN) to create a video series around the theme “Look Beyond My Skin,” featuring voices from all three organizations. Missed the videos on social media? Watch the full series on the IPC YouTube channel.

WATCH NOW

Thursday, October 29, 2026

Introducing Take Two with IPC: Expert Talks in Two Minutes

Take Two with IPC gives a longer presentation a second life in two minutes. Each video takes an expert talk IPC has already published (a Take Ten recording or a symposium presentation) and condenses the clinical substance. The series launched this month alongside the World Psoriasis Day campaign with four videos on pediatric psoriasis: Psoriasis Look-Alikes and Anti-TNF-α Induced Skin Eruptions with IPC Board Member Amy Paller, MS, MD; Conventional Therapies with IPC Councilor Mona El-Kalioby, MBBCh, MSc, MD; and Phototherapy in Pediatric Psoriasis with Fernando Valenzuela, MD. New Take Two videos will be featured each month, drawn from the Take Ten with IPC library and recordings from IPC symposia, with a link to the full presentation for each.

WATCH NOW

Thursday, October 29, 2026

Videos Now Available from the Eczema and Psoriasis Research Incubator

Select presentations from the Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum, hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the 55th Annual European Society for Dermatological Research (ESDR) Meeting, are now available. Topics include disease endotypes, atopic dermatitis-psoriasis overlap, cardiovascular risk in psoriasis, and genetic susceptibility.

WATCH NOW

Monday, October 26, 2026

Sex Differences in Psoriasis

In this Take Ten with IPC video, Juul van den Reek and PhD candidate Liana Barenbrug discuss sex differences in psoriasis, why these distinctions matter, what current research tells us, and which areas should be prioritized in future psoriasis research.

WATCH NOW

Thursday, October 1, 2026